| Filed On | Filing |
|---|---|
| 16 Jun 2022 |
8-K/A: Entry into a Material Definitive Agreement; Other Events
Cogent Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Jefferies LLC, Piper Sandler & Co. and Guggenheim Securiti... |
Loading...